Last reviewed · How we verify

NCT06163092

Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage

Recruiting now Last updated 20 March 2025
What this trial tests

trial in Recurrent Miscarriage in 175 participants. Currently enrolling.

Timeline
1 April 2024
Primary endpoint
31 January 2026
31 January 2027

Quick facts

Lead sponsorChinese University of Hong Kong
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment175
Start date1 April 2024
Primary completion31 January 2026
Estimated completion31 January 2027
Sites1 location across Hong Kong

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 20 to 45, female only, with Recurrent Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Recurrent Miscarriage

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing